Navigation Links
Invivo Wins Medical Design Excellence Award for Prostate Solutions
Date:8/3/2010

PEWAUKEE, Wis., Aug. 3 /PRNewswire/ -- On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award (MDEA) for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.

(Photo:  http://photos.prnewswire.com/prnh/20100803/SF44927)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100803/SF44927)

Invivo's DynaTRIM is the first commercially available fully MRI-compatible interventional device for Trans-Rectal Interventional MRI of the prostate gland. A removable device, DynaTRIM is designed to affix to an MR imaging table with an open design that allows for flexibility in coil choice and a cleanable foam pad for extra patient comfort. Invivo's DynaCAD for Prostate solution provides physicians with a comprehensive, customizable set of advanced visualization tools for performing real-time analysis of prostate MRI studies.

The pairing of DynaCAD for Prostate with DynaTRIM then enables a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy. "The better the sample, the more uniformity in diagnosis and inter-observer variance," explains Dr. David B. Kaminsky of Palm Springs Pathology Services. "I have personally witnessed the calm reception of the patient during set-up and biopsy procedure which cultivates the patient's participation in navigating his illness and reduces anxiety to foster compliance with the technique," he adds.

Bernadette Greenwood, Prostate Product Manager at Invivo adds, "The synergistic integration of two commercially available technologies is demonstrated illustrating the potential for fast, safe, and effective minimally invasive MR-guided prostate intervention. We are honored to be recognized for our prostate MR analysis clinical solutions by the MDEA, the premier awards program for the medical technology community."

The Medical Design Excellence Awards competition (www.MDEAwards.com) is organized and presented by Canon Communications LLC (Los Angeles) and is the only awards program that exclusively recognizes contributions and advances in the design of medical products. Entries are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and advancements from traditional medical attitudes or practices. Additional variables taken into account include the assessment of features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.

A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine and diagnostics.

Invivo is proud to receive such a prestigious award for its excellence in medical design. Invivo has an over 20-year history as the pioneer of progressive MRI coils, advanced clinical visualization systems, and MRI-compatible interventional devices. The Company prides itself on successfully developing and manufacturing high-value-added medical instruments that enhance MR image quality, improve physicians' diagnostic confidence and patients' health care experience. For more information please visit www.invivocorp.com.


'/>"/>
SOURCE Invivo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. invivodata Captures Symptom Relief Data in Endometriosis Trial
2. invivodata Certified to Deliver EXACT in COPD Trials
3. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Globus Medical Raises $110 Million in Series E Financing Round
8. Quark Pharmaceuticals Appoints New Chief Medical Officer
9. Boston University Biomedical Engineers Find Chink in Bacterias Armor
10. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
11. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Research and Markets has announced the ... their offering. ... R&D Drug Pipeline Database: 1-Year ... Drug Pipeline Database provides 24/7 online access to information about more ... and on investigational drug candidates in research & development. ...
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, un líder mundial ... el INSTI HIV Self Test , a los miembros de la Kenya ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue ...
(Date:12/2/2016)...  LifeVac, the revolutionary device that has successfully rescued ... Training and Support Services (ERTSS) training programs. ... part of the ERTSS mission to save lives," said ... "Having an established network of expert trainers demonstrating how ... our efforts to spread LifeVac,s message that choking deaths ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 ... are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This ... area students and operating support to UNCF-member institutions, including Miles College, Oakwood University, ...
(Date:12/2/2016)... , ... December 02, 2016 , ... The annual time ... Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are ... or prescription drug plan (Part D) need to make changes during this period order ...
Breaking Medicine News(10 mins):